Indian in vitro diagnostics market opportunity analysis 2018 - Reports CornerReports Corner
The Indian IVD market is valued at more than US$ 500 Million, and is expected to touch the US$ 1 Billion in 2016 growing steady at a CAGR of 19%. This remarkable growth can be attributed to increased healthcare awareness, desire to undergo preventive health checkups, availability of disease specific tests, corporate setups promoting health focus of employees, and drift from manual to semi-automated and automated equipment.
https://www.reportscorner.com/reports/16265/Indian-In-Vitro-Diagnostics-Market-Opportunity-Analysis-2018/
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Indian in vitro diagnostics market opportunity analysis 2018 - Reports CornerReports Corner
The Indian IVD market is valued at more than US$ 500 Million, and is expected to touch the US$ 1 Billion in 2016 growing steady at a CAGR of 19%. This remarkable growth can be attributed to increased healthcare awareness, desire to undergo preventive health checkups, availability of disease specific tests, corporate setups promoting health focus of employees, and drift from manual to semi-automated and automated equipment.
https://www.reportscorner.com/reports/16265/Indian-In-Vitro-Diagnostics-Market-Opportunity-Analysis-2018/
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
"Description:
Red biotechnology (RB) refers to the biotechnology applied in pharmaceutical production and it has become the most important part in biotechnology industry. About 60% of achievements in biotechnology in the world are applied in production of bio-pharmaceuticals. At present, RB products mainly include gene recombinant drugs, blood products, vaccines, diagnostic reagents, etc. What is the current production situation of different RB products in China?
Driven by its substantial environmental or economic benefits, China’s RB industry has witnessed fast development and has played an increasingly important role in Chinese economic growth. However, the overall development of China’s RB industry remains in growth stage, and still has an enormous gap compared with developed countries. What is the future trend of Chinese RB industry development? What are the relevant supporting policies on Chinese RB industry? What have been the popular cutting-edge technologies in China in recent years? Where are the investment opportunities and what is the investment mode in China?
What is covered in this report?
- Overview of China’s red biotechnology;
- Detailed analysis of each sub-categories of red biotechnologies in China: gene recombinant drugs, blood products, vaccines, diagnostic reagent, etc., in terms of market data, major players, technical suppliers, technologies or R&D situations;
- Future prospects of each category of red biotechnologies, with key influencing factors and commercial opportunities
- Profiles of major players and research institutes
- Related policies and regulations
What benefits will you get?
- Gain a clear understanding about the industry landscape and latest developments in R&D, production, technology advancement and future trends in China’s red biotechnology;
- Keep informed of the precise development situation of key RB products with basic data and latest info;
- Gain reasonable and constructive suggestions on market opportunities in China’s RB fields;
- Figure out, current trend and future growth prospect of red biotechnology in China;
- Know more about how innovative players and research groups are carrying out innovation, collaboration and achieving commercial success in China.
"
mHealth Israel_Rambam Health Care Campus_Miki HalberthalLevi Shapiro
Presentation by Miki Halberthal, CEO, Rambam Health Care Campus, for the mHealth Israel community, May, 2020. Includes Rambam financials, sector growth, innovation into practice, ingredients of success, overview of Rambam Innovation Hub, tech transfer, bio bank, clinical research, clinical trials, medtech, CoVID response, etc
Just like every other nation, Australia has also taken several measures to respond to the global pandemic. To help prevent shortages of medical equipment and personal protective equipment, the Australian regulating authority- Therapeutic Goods Administration (TGA) has announced several exemptions and expedited paths to ensure an adequate supply of medical products...
Medical device industry 2014 - A Healthcare Sector AnalysisVikas Soni
Medical Device Industry and its impact on Healthcare Sector of India for FY2014 along with Current Scenario of Global, US, EU and Indian Medical device market.
Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...Aiswariya Chidambaram
The Indian Pharmaceutical CMO market has been analyzed and assessed with respect to APIs and finished dose formulations (solids, liquids and injectables). Strategic recommendations for the success of market participants have been provided.
This report provides comprehensive information on the therapeutic development for Rhabdomyosarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rhabdomyosarcoma and special features on late-stage and discontinued projects.
http://www.researchmoz.us/rhabdomyosarcoma-pipeline-review-h1-2015-report.html
This report provides comprehensive information on the therapeutic development for Traveler's Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Traveler's Diarrhea and special features on late-stage and discontinued projects.
http://www.researchmoz.us/travelers-diarrhea-pipeline-review-h1-2015-report.html
Endoscope Reprocessing Market PPT: Overview, Dynamics, Trends, Segmentation, ...IMARC Group
The global endoscope reprocessing market size reached US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032.
More Info:- https://www.imarcgroup.com/endoscope-reprocessing-market
Glucose Strip, Urine Strip and Pregnancy Strip are three categories of IVD Strips that required to manufacturing in good quality and cost effective manner with accurate release timing and effective marketing strategy. To manufacture these strips, it should be well equipped with infrastructure, experienced team of research experts, proper regulatory compliances, dedicated lab facility and well developed supply chain network.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐮𝐬
NIIR PROJECT CONSULTANCY SERVICES, DELHI
An ISO 9001:2015 Company
ENTREPRENEUR INDIA
106-E, Kamla Nagar, Opp. Mall ST,
New Delhi-110007, India.
Email: npcs.ei@gmail.com
info@entrepreneurindia.co
Tel: +91-11-23843955, 23845654, 23845886
Mobile: +91-9097075054, 8800733955
Website: https://www.entrepreneurindia.co
https://www.niir.org
Medical Nonwoven Disposables Market | Growth | Trends | Forecast to 2022-2027IMARC Group
According to the latest report by IMARC Group, the global medical nonwoven disposables market size reached US$ 10.8 Billion in 2021. Medical nonwoven disposables are a class of textile materials that are bonded together to form a lucid structure. Some commonly used medical nonwoven disposables include face masks, surgical gowns, nurse caps, surgeon caps, lab coats, bed linens, and shoe covers. They are made from natural fiber-like cotton, linen, or synthetic materials such as polypropylene, polyester, and polytetrafluoroethylene (PTFE).
In-Vitro Diagnostics Packaging Market PPT 2021: Size, Growth, Demand and For...IMARC Group
According to the latest report by IMARC Group,the global in-vitro diagnostics packaging market size reached US$ 6.7 Billion in 2020.In-vitro diagnostics (IVDs) refer to the various kinds of medical devices and accessories that are widely used for performing tests on samples. These equipment assist in analyzing several bodily fluids, such as urine, stool and blood, to detect diseases and infections. These tests are utilized to assist in monitoring drug therapies while facilitating the early diagnosis of chronic diseases at the initial stage.
"Description:
Red biotechnology (RB) refers to the biotechnology applied in pharmaceutical production and it has become the most important part in biotechnology industry. About 60% of achievements in biotechnology in the world are applied in production of bio-pharmaceuticals. At present, RB products mainly include gene recombinant drugs, blood products, vaccines, diagnostic reagents, etc. What is the current production situation of different RB products in China?
Driven by its substantial environmental or economic benefits, China’s RB industry has witnessed fast development and has played an increasingly important role in Chinese economic growth. However, the overall development of China’s RB industry remains in growth stage, and still has an enormous gap compared with developed countries. What is the future trend of Chinese RB industry development? What are the relevant supporting policies on Chinese RB industry? What have been the popular cutting-edge technologies in China in recent years? Where are the investment opportunities and what is the investment mode in China?
What is covered in this report?
- Overview of China’s red biotechnology;
- Detailed analysis of each sub-categories of red biotechnologies in China: gene recombinant drugs, blood products, vaccines, diagnostic reagent, etc., in terms of market data, major players, technical suppliers, technologies or R&D situations;
- Future prospects of each category of red biotechnologies, with key influencing factors and commercial opportunities
- Profiles of major players and research institutes
- Related policies and regulations
What benefits will you get?
- Gain a clear understanding about the industry landscape and latest developments in R&D, production, technology advancement and future trends in China’s red biotechnology;
- Keep informed of the precise development situation of key RB products with basic data and latest info;
- Gain reasonable and constructive suggestions on market opportunities in China’s RB fields;
- Figure out, current trend and future growth prospect of red biotechnology in China;
- Know more about how innovative players and research groups are carrying out innovation, collaboration and achieving commercial success in China.
"
mHealth Israel_Rambam Health Care Campus_Miki HalberthalLevi Shapiro
Presentation by Miki Halberthal, CEO, Rambam Health Care Campus, for the mHealth Israel community, May, 2020. Includes Rambam financials, sector growth, innovation into practice, ingredients of success, overview of Rambam Innovation Hub, tech transfer, bio bank, clinical research, clinical trials, medtech, CoVID response, etc
Just like every other nation, Australia has also taken several measures to respond to the global pandemic. To help prevent shortages of medical equipment and personal protective equipment, the Australian regulating authority- Therapeutic Goods Administration (TGA) has announced several exemptions and expedited paths to ensure an adequate supply of medical products...
Medical device industry 2014 - A Healthcare Sector AnalysisVikas Soni
Medical Device Industry and its impact on Healthcare Sector of India for FY2014 along with Current Scenario of Global, US, EU and Indian Medical device market.
Strategic Analysis of the Indian Pharmaceutical Contract Manufacturing Market...Aiswariya Chidambaram
The Indian Pharmaceutical CMO market has been analyzed and assessed with respect to APIs and finished dose formulations (solids, liquids and injectables). Strategic recommendations for the success of market participants have been provided.
This report provides comprehensive information on the therapeutic development for Rhabdomyosarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rhabdomyosarcoma and special features on late-stage and discontinued projects.
http://www.researchmoz.us/rhabdomyosarcoma-pipeline-review-h1-2015-report.html
This report provides comprehensive information on the therapeutic development for Traveler's Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Traveler's Diarrhea and special features on late-stage and discontinued projects.
http://www.researchmoz.us/travelers-diarrhea-pipeline-review-h1-2015-report.html
Endoscope Reprocessing Market PPT: Overview, Dynamics, Trends, Segmentation, ...IMARC Group
The global endoscope reprocessing market size reached US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032.
More Info:- https://www.imarcgroup.com/endoscope-reprocessing-market
Glucose Strip, Urine Strip and Pregnancy Strip are three categories of IVD Strips that required to manufacturing in good quality and cost effective manner with accurate release timing and effective marketing strategy. To manufacture these strips, it should be well equipped with infrastructure, experienced team of research experts, proper regulatory compliances, dedicated lab facility and well developed supply chain network.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐮𝐬
NIIR PROJECT CONSULTANCY SERVICES, DELHI
An ISO 9001:2015 Company
ENTREPRENEUR INDIA
106-E, Kamla Nagar, Opp. Mall ST,
New Delhi-110007, India.
Email: npcs.ei@gmail.com
info@entrepreneurindia.co
Tel: +91-11-23843955, 23845654, 23845886
Mobile: +91-9097075054, 8800733955
Website: https://www.entrepreneurindia.co
https://www.niir.org
Medical Nonwoven Disposables Market | Growth | Trends | Forecast to 2022-2027IMARC Group
According to the latest report by IMARC Group, the global medical nonwoven disposables market size reached US$ 10.8 Billion in 2021. Medical nonwoven disposables are a class of textile materials that are bonded together to form a lucid structure. Some commonly used medical nonwoven disposables include face masks, surgical gowns, nurse caps, surgeon caps, lab coats, bed linens, and shoe covers. They are made from natural fiber-like cotton, linen, or synthetic materials such as polypropylene, polyester, and polytetrafluoroethylene (PTFE).
In-Vitro Diagnostics Packaging Market PPT 2021: Size, Growth, Demand and For...IMARC Group
According to the latest report by IMARC Group,the global in-vitro diagnostics packaging market size reached US$ 6.7 Billion in 2020.In-vitro diagnostics (IVDs) refer to the various kinds of medical devices and accessories that are widely used for performing tests on samples. These equipment assist in analyzing several bodily fluids, such as urine, stool and blood, to detect diseases and infections. These tests are utilized to assist in monitoring drug therapies while facilitating the early diagnosis of chronic diseases at the initial stage.
Indian Vaccine Market by Product Type, Distribution Channel, End User 2024-2032IMARC Group
The Indian vaccine market size is expected to exhibit a growth rate (CAGR) of 12.3% during 2024-2032.
More Info:- https://www.imarcgroup.com/indian-vaccine-market
As of my last knowledge update in September 2021, the list of the top Contract Research Organizations (CROs) can vary depending on factors such as revenue, services offered, therapeutic areas of expertise, and global presence. The following list includes some of the prominent CROs based on their reputation, scale, and contributions to the clinical research industry:
IQVIA (formerly QuintilesIMS):
IQVIA is one of the largest CROs in the world, offering a wide range of services including clinical development, real-world evidence solutions, commercialization services, and consulting. They have a vast global network and expertise across various therapeutic areas.
PPD (Pharmaceutical Product Development):
PPD is known for its comprehensive clinical trial services, laboratory services, and real-world evidence solutions. They have a strong global presence and experience in managing trials of varying complexity.
Covance:
Covance, a subsidiary of LabCorp, is known for its extensive portfolio of drug development services including clinical development, central laboratory services, and market access solutions. They have experience in a broad range of therapeutic areas.
Syneos Health:
Syneos Health offers integrated solutions across clinical development, commercialization, and real-world evidence. They focus on helping clients navigate the entire drug development journey.
ICON:
ICON provides a variety of clinical research services, including consulting, clinical trial execution, laboratory services, and outcomes research. They have expertise in a wide array of therapeutic areas.
Parexel:
Parexel offers services ranging from clinical research and regulatory consulting to market access and commercialization. They are known for their global reach and innovative approach to clinical trials.
WuXi AppTec:
WuXi AppTec is a global company that provides a wide range of R&D services, including preclinical and clinical development, manufacturing, and regulatory services.
Medpace:
Medpace is known for its focused and customized approach to clinical trial management, particularly in the area of complex and specialized studies.
Celerion:
Celerion specializes in early-stage clinical research, with a focus on providing solutions for both small and large molecules.
Charles River Laboratories:
While Charles River Laboratories primarily focuses on preclinical research, they also offer a range of early-stage clinical development services.
Anesthesia Endotracheal Tubes Market by Product Type, Distribution Channel, E...IMARC Group
The global anesthesia endotracheal tubes market size reached US$ 162.8 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 227.3 Million by 2027, exhibiting a growth rate (CAGR) of 5.83% during 2022-2027.
More Info:- https://www.imarcgroup.com/anesthesia-endotracheal-tubes-market
Remote Patient Monitoring Market PPT 2022: Size, Growth, Demand and Forecast ...IMARC Group
Looking forward, the remote patient monitoring market value is projected to reach a strong growth during the forecast period (2022-2027).
More info:- https://www.imarcgroup.com/remote-patient-monitorning-market
Global Breathable Films Market PPT: Demand, Trends and Business Opportunities...IMARC Group
According to the latest report by IMARC Group,finds that the global breathable films market size reached US$ 3.33 Billion in 2021.Breathable films are cost-effective, polymer-based films that are manufactured using thermoplastic resins via extrusion technology. They provide moisture control in various products, including diapers, feminine hygiene, and incontinence protection products where breathability is an essential parameter of user comfort.
Cholera Vaccines Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and ...IMARC Group
The global cholera vaccines market size reached US$ 5.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.0 Million by 2032, exhibiting a growth rate (CAGR) of 10% during 2024-2032.
More Info:- https://www.imarcgroup.com/cholera-vaccines-market
Microneedles for drug delivery patent landscape 2020 flyerKnowmade
Report’s Key Features
• PDF with > 140 slides
• Excel file > 2,450 patent families
• IP trends, including time-evolution of published patents, and countries of patent filings
• Patents’ legal status
• Ranking of main patent assignees
• Key players’ IP position and relative strength of their patent portfolios
• Summary of the IP related to applications: Cancer therapy, Cosmetic, Diabetes, Ophthalmic, Pain management and Vaccine.
• Summary of the IP related to technologies: Applicators, housing, Coated, Hollow, Porous, Soluble, Hydrogel and Solid microneedles.
• Analysis of patent oppositions (Europe) and review of key patents.
• Excel database containing all patents analyzed in the report, including applications and technologies segmentations
Vaccine Storage and Packaging Market PPT 2021-26 | Enhancing Huge Growth and ...IMARC Group
According to the latest report by IMARC Group,The global vaccine storage and packaging market reached around US$ 21.8 Billion in 2020.Vaccine storage and packaging are laboratory devices that are utilized to preserve and store vaccines in optimum temperatures and ensure proper handling of vaccine vials and ampoules during transportation and storage. These storage solutions, including refrigerators and freezers, are widely available in a vast range of capacities that vary depending upon the user requirements.
Remote Patient Monitoring Market PPT: Trends and Dynamics, Drivers, Competiti...IMARC Group
The global remote patient monitoring market size reached US$ 1.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2028, exhibiting a growth rate (CAGR) of 15.4% during 2023-2028.
More Info:- https://www.imarcgroup.com/remote-patient-monitorning-market
Pediatric Vaccines Market Growth, Demand and Challenges of the Key Industry P...IMARC Group
The global pediatric vaccines market size reached US$ 37.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 70.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.26% during 2024-2032.
More Info:- https://www.imarcgroup.com/pediatric-vaccines-market
Medical Swabs Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...IMARC Group
The global medical swabs market size reached US$ 3.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4.6% during 2023-2028.
More Info:- https://www.imarcgroup.com/medical-swabs-market
PPT-Computational Biology Market Growth, Demand and Challenges of the Key In...IMARC Group
According to the latest report by IMARC Group, the global computational biology market reached a value of US$ 3.9 Billion in 2021. Computational biology refers to a branch of biology that involves the application of computer science to study the processes of life. It involves the utilization of various computational methods for the simulation and representation of biological systems on a large scale. Some of the popular adopted methods include algorithms, machine learning (ML), statistical physics, robotics and complexity theory that aid in determining the cellular function and treatment for multiple diseases.
PPT: Medical Cyclotron Market to Witness Huge Growth during 2022-2027IMARC Group
According to the latest report by IMARC Group, the global medical cyclotron market reached a value of US$ 192.6 Million in 2021. Medical cyclotron represents a type of particle accelerator, wherein an alternating electric field propels a beam of charged units in a spiral pattern. This assists in producing protons and radioactive isotopes for medical imaging, diagnosis, and treatment of various cardiovascular disorders.
Biobanking Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opport...IMARC Group
The global biobanking market size reached US$ 57.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 82.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.86% during 2023-2028.
More Info:- https://www.imarcgroup.com/biobanking-market
Course:- Organizational Behavior
Faculty:-
Sir Mir Akbar Ali Khan
Group Members
M Owais 55012
Mehdi Abbass 55246
Ali Arshad 55017
Tariq Mehmood 56908
Sagar Kumar 5632
Course:- Organizational Behavior
Faculty:-
Sir Mir Akbar Ali Khan
Group Members
M Owais 55012
Mehdi Abbass 55246
Ali Arshad 55017
Tariq Mehmood 56908
Sagar Kumar 5632
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
NVBDCP.pptx Nation vector borne disease control program
Corona Pandemic (Effect in 2nd & 3rd Phase) 2020/2021 on Medical Industry
1. April 26, 2020 1
ASSIGNMENT # O4
WHAT ARE THE CORONA PANDEMIC EFFECTS IN 2ND
AND 3RD
QUARTER OF THE YEAR 2020 AND FURTHERMORE IN 2021???
INDUSTRY:
DIAGNOSTICS
COMPANY/ORGANIZATION
KEYYANI MEDICAL SOLUTIONS
CLASS:
MS IN MANAGEMENT SCIENCES
GROUP MEMBERS
1-SAEED AHMED
2-TARIQ MEHMOOD
3-MUHAMMAD SIKANDER IQBAL - 10952
2. April 26, 2020 2
INTRODUCTION OF INDUSTRY:DIAGNOSTIC INDUSTRY OF
PAKISTAN:
PAKISTAN medical devicesanddiagnosticindustryisestimatedtoworth approx. $600mn in 2017. The
industryisprimarilyimportdrivenasover90% medical devicesanddiagnosticproductsconsumedin
Pakistanare importedfromvariouspartsof the world.Pakistanisknownforexportof fine quality
surgical instrumentsfromSialkotwhichcontributessignificantlyinthe country’sGDP.
There are veryfewMD&D multinationalsoperatingwithinPakistanwhereasmostof the MNCs are
representedthroughvariousimporters/distributors.The medical devicesanddiagnosticindustryisin
processof recentlyimplementedregulationbygovernmentthroughMedical DeviceRules,2017 as the
governmentaimstoregulate all MD&Dproducts inthe nextcouple of years.
The medical device industryisestimatedatUS$150bn worldwide asmedical deviceshave now become
indispensable toolsinmodernclinical practice.MD&Dindustryisrepresentedthrough‘Healthcare
DevicesAssociationof Pakistan’ (HDAP) whichisa veryactive associationof medical devices&
diagnosticindustrystakeholdersinPakistan.
The product range of medical devices&diagnosticindustryisequallydiverseandincludesdisease
screeningtechnologies,therapies,equipmentandsupplies–From simple productslikebandages,tapes
& syringestoheavilycomplexcapital equipmentlike MRIscanners& ICU ventilatorsandhighly
researched&developedproductslikeimplantable devices.
There are a range of businesstypesthatmake upthe medical devices&diagnosticindustryinPakistan.
1. Importer of medical devices& diagnosticas subsidiaryof multinational company
An importerof medical devices&diagnosticwhere the Pakistanicompanyisasubsidiaryof the
same multinationalcompany.Usually,mostof the productssoldwill be fromthe parentcompany.
2. Third party importerof medical devices& diagnostic
An importerof medical devices&diagnosticthatisnota subsidiaryof amultinational companybut
a local company.Usuallysuchlocal companiesare importerof several multinational companies.
3. Supplier/Distributorof medical devices& diagnosticmanufactured
A supplier/distributorof medical devices&diagnosticwhoprocuresproductsfromimporteror
thirdparty importerof medical devicesanddiagnosticsinPakistan
4. Manufacturer of medical devices& diagnostics
A manufacturerof medical devices&diagnosticsinPakistanwhichcaneitheralocallyowned
companyor a subsidiaryof amultinational company.
3. April 26, 2020 3
COVID 19 EFFECTS ON DIANOSTIC INDUSTRY OF PAK
Diagnostic industry of Pakistan import 90% products throughout the world and mainly from
china, but China’s exports contracted sharply in the first two months of the year, as the fast
spreading coronavirus outbreak caused massive disruptions to business operations, global
supply chains and economic activity.
There are multiple effects of covid 19 on diagnostic industry of Pakistan.
Import is a big issue for industry to run business in a smooth way ,By import issues
globally, leads to business downfall as product not reached at right time and in the same
way supply of the product could not reached at right time in healthcare institutes /
hospitals /laboratories performing multiple test and reports as well.
Patients are also suffered from this delay, in ICU patients required ventilators,
unfortunately in this pandemic most of the healthcare institutes don’t have enough
amount of ventilators to save patients life as patients increased because of low
immunity level of the senior citizens.
Corona virus spreading its wings in China and other parts of the world continuously now,
Pakistani business community got alternatives and manufacturing local products to get
rid of this business downfall and covid19 as well. For example locally made sanitizers,
alcoholic products, face mask etc...
4. April 26, 2020 4
KARACHI IS A BIG MARKET:
Karachi is in lockdown condition nowadays, so the multination organizations are
partially closed, local markets are open in specific timings, so big suppliers got
product from local manufacturers for Health care institutes/hospital/medical
laboratoriesto best care of an individual.
5. April 26, 2020 5
INTRODUCTION OF COMPANY:KEYYANI MEDICAL SOLUTIONS
Keyyani Medical Solutions(KMS) isspecializedinthe supplyof Laboratory,Hospital and Medical
equipmentfromreputable American,EuropeanandCanadiansuppliers,namelyinBloodBanking,Micro
plate Technology,Industrial MicrobiologyandControlledEnvironment.
Alongwiththe supplyanddeliveryof the capital equipment,we ensure toprovide sales,marketing,
after-sale,service supportandstockingdistributiontoourcustomersandend-usersviaourspecialized
networkof local dealers.
DIAGNOSTICproductsmanufacturinginDifferent partof the worldandlocal supplywithinthe country.
KMS can provide consultingservicesforsite planningandproductrequirements(BOQ) forBloodBanks,
Hospitals,Laboratories,ResearchCentersandUniversitiesinbothprivate andpublicsectors.
Extensive productportfoliothatincludesthe KMSProductbrand for basicLaboratory and BloodBank
instrumentlike Bloodcollectiontubes,test tubes,serologicalpipetts,hitachicups,microbiologicalkit,Elisa
kits,biochemistry kits,blood bags,cryo-freezingbags,centrifugemachines,biological safetycabinets,
pharmacyrefrigeratorsandso on….
The KMS networkof local distributorsandKMSin-house engineerscanassistwith:
Servicingof Instruments
Installation,Commissioning,Training
Spare Parts Availability
MarketingSupport
6. April 26, 2020 6
INTERNAL FACTORS:
FINANCE:
The CEO of companyworkas a CFOof the company.He is mindful forthe speculations within
the company. Companyhas a few issuessituateditemswhichofferassistance torunits money
relatedcycle.5-(F-S)
HRM:
HR division comprise of one HRmanagerand one operational head.Eachhave diverse work Duties.One
isfor keepingup payroll, motivatingforces; costetc. 2nd
isfor preparingof workers.1-(HR-S)
SALES AND MARKETING:
Dealsand promotingisdone bythe field drive.Itcomprises of approx., more than12 workers all over
the Pakistan at highpayingsalaries. Astheycompany’s centerobjective is deal soitisthe
foremostpotentialoffice of the company. Nowadays circumstance the company presents sanitizers/
face mask / corona dresskits whichison tall requestinthiswidespread circumstance.2,3-(S-S)
PROCUREMENT:
KMS have 90% importedbrandsthan neighborhood fabricating.Importedbrandsare obtained by
the obtainmentoffice andthe neighborhood fabricatingitemsare made bythe thirdparty.
An enormous shortcomingisof the imported itemssince momentisprohibited inthesedays.More
overincase purportwill be permitted sothe fabricatingof these imported itemsis
additionally prohibited intheirparentfabricatingcompany since of lockdown.4,6-(P-W)
7. April 26, 2020 7
EXTERNAL FACTORS:
1-ECONOMICAL:
Economic element is immediately involved in company.AsiCompany is doingnicely and involvein all theactivities
which make the company grow in the industry t’s normally brands areimported so the fluctuation of dollar will
come to be once in a whilea possibility or someday Loss for the Company due to exchange of economy.9-(E-T)
This COVID state of affairs will beultimatetwo months greater because ORGANIZATION is a salesbased,so
company took some steps to collaboratewith local manufacturer / local suppliers to recover its somehow loss.
10-(E-O)
2-SOCIAL:
It’san accurate probability forthe organization todeal in these products whichare wishedinthese
COVID-19pandemicconditions asemployerisflexibleinlocal manufacturingmerchandise and
the businessenterpriseislookup oriented(1-socialopp).
3-POLITICAL:
The general modifications inthe HDAP/ DRAP licensingcommittee sometimescreate Political problems.
Andthe adjustments inthe rulesandlegislation orthe taxesandauthoritiesof importisa dangerfor
the organization.3,4-(T)
4-GLOBAL:
CompanyisworkinginPakistan only there isno internationalpresence of the employer.6-(G-T)
5-DEMOGRAPHIC:
PopulationSize of KEYYANIMEDICALSOLUTIONS crew consistof around 50 core businesscustomersall
overthe Pakistan whoare willingtopurchasingdiagnostic&surgical products.5-(D-0)
Shiffainternational hospital Islamabadisourcore customerof thisCYOFREEZING BAG product. 11-(D-
O)
8. April 26, 2020 8
6-TECHNOLOGICAL:
CryoMACSFreezingBags are forcryopreservationapplicationsat ultra-low temperatures.The
CryoMACSFreezingBags are intendedforasingle cycle of freezing,storage (downto-196°C),and
subsequentthawing(at37°C) of hematopoieticprogenitorcells2-.(T-O)
Shiffainternational hospital Islamabadisourcore customerof thistechnological product.
7-COMPETITOR:
Some of the Competitorsare Imranscientificcompany,musajiAdam&sons,Allmedsolutions.7-(C-T)
8-INDUSTRY:
Companyisdoingnicely andinvolve inall the activitieswhichmake the company grow inthe industry.8-
(I-O)
9. April 26, 2020 9
EXTERNAL DATA:
External
(O & T)
Macro
Economic
10. becauseORGANIZATION is a sales based,so company took some steps to collaborate
with local manufacturer / local suppliersto recover its somehow loss.(O)
9.Normally brands areimported so the fluctuation of dollar will cometo be once in a
whilea possibility or someday Loss for the Company due to exchange of economy. (T)
Social
1.COVID-19
pandemicconditions asemployerisflexible inlocal manufacturingmerchandise a
nd the business enterprise is lookup oriented.(O)
Technological
2.CryoMACS FreezingBags are intendedforasingle cycle
of freezing,storage (downto-196°C),and subsequentthawing(at37°C) of
hematopoieticprogenitorcells...(O)
Political/Legal
3.The HDAP/DRAPlicensingcommittee sometimescreate Political problems.(T)
4.Adjustments inthe rulesandlegislation orthe taxesandauthoritiesof importis
a dangerfor the organization...(T)
Demographic
5 PopulationSize of KEYYANIMEDICALSOLUTIONS crew consistof around50 core
businesscustomersall overthe Pakistan whoare willingtopurchasingdiagnostic
& surgical products..(O)
11-Shiffainternational hospital Islamabad iscore customerof thisCYOFREEZING
BAG product.(O)
Global
6. CompanyisworkinginPakistan only there isno international presence of
the employer...(T)
Micro
Competitor
7. Competitorsare Imranscientificcompany,musaji Adam&sons,Allmed
solutionsetc....(T)
Industry
8. Companyisdoingnicely andinvolveinall the activities whichmake
the company grow inthe industry.(O)
10. April 26, 2020 10
INTERNAL DATA :
Internal
(S&W)
FINANCE
5. The CEO of companyworkas a CFO of the company.He is mindful for
the speculations withinthe company.Companyhas afew issuessituateditemswhichoffer
assistance torun itsmoneyrelated cycle.(S)
HR
1. HR division compriseof one HRmanagerand one operational head.Each
have diverse work Duties.One isforkeepingup payroll, motivatingforces; costetc. 2nd
isfor preparingof workers (S)
Marketing
2. More than12 workers all overthe Pakistanathighpayingsalaries...(S)
Procuremen
t
4. KMS have 90% importedbrandsthan neighborhood fabricating.(W)
6-The neighborhood fabricatingitemsare made bythe thirdparty...(W)
Sale
3.. Nowadays circumstance the company presents sanitizers/face mask/corona dress
kitswhichison tall requestinthis widespread circumstance…(S)
11. April 26, 2020 11
STRENGTH:S
5-The CEO of company work as a CFO of the company. He is mindful for the speculations within thecompany. Company has a
few issues situated items which offer assistanceto run its money related cycle .(S)
1. HR division compriseof one HR manager and one operational head.Each have diversework Duties. One is for keeping up pay
roll,motivatingforces;cost etc. 2nd is for preparing of workers (S)
2. More than 12 workers all over the Pakistan athigh payingsalaries...(S)
3.. Nowadays circumstancethe company presents sanitizers / facemask / corona dress kits which is on tall request in
this widespread circumstance…(S)
WEAKNESS:
4. KMS have 90% imported brands than neighborhood fabricating.(W)
6-The neighborhood fabricating items aremade by the third party...(W)
OPPORTUNITY:
10. because ORGANIZATION is a sales based,so company took some steps to collaboratewith local manufacturer / local suppliersto
recover its somehow loss.(O)
1.COVID-19 pandemic conditions as employer is flexiblein local manufacturing merchandiseand the business
enterprise is lookup oriented.(O)
2.CryoMACS Freezing Bags are intended for a singlecycleof freezing, storage(down to -196°C), and subsequent thawing (at 37°C) of
hematopoietic progenitor cells...(O)
5 Population Sizeof KEYYANI MEDICAL SOLUTIONS crew consistof around 50 core business customers all over the Pakistan who
are willing to purchasing diagnostic & surgical products..(O)
11-Shiffa international hospital Islamabad is corecustomer of this CYOFREEZING BAG product.(O)
8. Company is doing nicely and involvein all theactivities which makethe company grow in the industry.(O)
THREAT:
9. Normally brands areimported so the fluctuation of dollar will cometo be once in a whilea possibility or someday Loss for the
Company due to exchange of economy. (T)
3. The HDAP/ DRAP licensingcommittee sometimes create Political problems.(T)
4. Adjustments in the rules and legislation or the taxes and authorities of import is a danger for the organization...(T)
6. Company is workingin Pakistan only there is no international presenceof the employer...(T)
7. Competitors areImran scientific company,musaji Adam& sons,Allmed solutions etc....(T)
12. April 26, 2020 12
SWOT ANALYSIS
INTERNAL FACTOR EVALUATION (IFE) MATRIX
(Rating Strength 3 and 4, Weakness 1 and 2)
Key Internal Factor Weight Rating
Weighte
d Score
S.No Strength
1. 5-The CEO of company work as a CFO of the company. He is mindful for
the speculations within thecompany. Company has a
few issues situated items which offer assistanceto run its money related cycle .(S)
0.3 4 1.2
2. 2. More than 12 workers all over the Pakistan athigh payingsalaries...(S) 0.2 3 0.6
3. 3.. Nowadays circumstancethe company presents sanitizers / facemask / corona
dress kits which is on tall request in this widespread circumstance…(S)
0.05 4 0.2
4. 1. HR division compriseof one HR manager and one operational head.Each
have diversework Duties. One is for keeping up pay roll,motivating
forces; costetc. 2nd is for preparing of workers (S)
0.2 4 0.8
WEAKNESS:
5.
4. KMS have 90% imported brands than neighborhood fabricating.(W)
0.2 2 0.4
6. 6-The neighborhood fabricating items aremade by the third party...(W) 0.05 2 0.1
TOTAL 1.00 3.3
IFE MATRIX RESULTS:
Accordingto the internal factorsKEYYANI medical answerperformance isvery suitable because the
weighted ratingis3.3 sowe are anticipatingmore opportunities infuture.Now we canconclude that
13. April 26, 2020 13
company’sresponse to interiorstrength&weakness are above average &KMS diagnosticemployerisin
favorable conditions
EXTERNAL FACTOR EVALUATION (EFE) MATRIX
(Rating 1 to 4)
Key Internal Factor Weight Rating
Weighte
d Score
S.No OPPORTUNITIES
1. 5 Population Sizeof KEYYANI MEDICAL SOLUTIONS crew consistof around 50
core business customers all over the Pakistan who
are willing to purchasing diagnostic & surgical products..(O)
0.3 4 1.2
2. 2.CryoMACS Freezing Bags are intended for a singlecycle
of freezing, storage (down to -196°C), and subsequent thawing (at 37°C) of
hematopoietic progenitor cells...(O)
0.2 4 0.8
3. 10. because ORGANIZATION is a sales based,so company took some steps to
collaboratewith local manufacturer / local suppliers to recover its somehow
loss.(O)
0.03 3 0.09
4. 1.COVID-19
pandemic conditions as employer is flexiblein local manufacturing merchandise
and the business enterpriseis lookup oriented.(O)
0.02 3 0.06
5 11-Shiffa international hospital Islamabad is corecustomer of this CYOFREEZING
BAG product.(O)
0.1 4 0.4
6 8. Company is doing nicely and involvein all theactivities which make
the company grow in the industry.(O
0.04 2 0.08
THREATS:
7
9. Normally brands areimported so the fluctuation of dollar will cometo be once
in a while a possibility or someday Loss for the Company due to exchange of
economy. (T)
0.1 `3 0.3
14. April 26, 2020 14
8.
7. Competitors areImran scientific company,musaji Adam& sons,Allmed
solutions etc....(T) 0.03 2 0.06
9 3. The HDAP/ DRAP licensingcommittee sometimes create Political problems.(T) 0.1 4 0.4
10
4. Adjustments in the rules and legislation or the taxes and authorities of import
is a danger for the organization...(T) 0.04 1 0.04
11
6. Company is workingin Pakistan only there is no international presenceof
the employer...(T) 0.04 3 0.12
TOTAL 1.00 3.55
EFE MATRIX RESULTS::
Accordingto the external factors keyyani medialsolution overall performance is
very properbecause the weighted score is3.55 so we are lookingforwardto greateropportunities in
future.The company’s response to externalopportunities &threatsisabove average &employerisin
favorable condition.
15. April 26, 2020 15
COMPETITIVE PROFILE (CPM) MATRIX:
CPM “identifies a firm’s important opponents and its precise strength and weaknesses in relation to
a pattern firm’s strategic position”. The opponents of KMS organization are Imran scientific company,
musajiAdam&sons, Allmed solutions etc.…
CPM RESULTS
Critical successfactorsreferredasstrengthandweaknessrespectivelyinternalandexternal.
Scoring1 as more weakenedand4as more strengthen…
By CPMIMRAN SCIENTIFICCOMPANYisdominantoverKMS,scoringhighas 3.62 got 1st
position,KMS
got 2nd
positionscoringas 3.42.
COMPETITORS IMRAN SCIENTIFIC
COMPANY
KEYYANI MEDICAL SOLUTIONS
CRITICAL SUCCESS FACTORS WEIGHT SCORE WEIGHTED SCORE SCORE WEIGHTED SCORE
QUALITY OF PRODUCT 0.4 4 1.6 4 1.6
BRAND MARKETING 0.2 3 0.6 2 0.4
PRODUCT SUPPLY 0.3 4 1.2 3 0.09
CUSTOMER LOYALTY 0.05 2 0.1 1 0.05
NUMBER OF PRODUCTS 0.03 2 0.06 4 1.2
BRAND REPUTATION 0.02 3 0.06 4 0.08
Total 1.0 3.62 3.42
17. April 26, 2020 17
Perceptual Mapping:
Perceptual map:
A perceptual map is of the visible approach designed to show how the average target market client is
aware the positioning of the competing products in the marketplace
Perceptual mapping of KMS:
Nowwe use perceptual mappingof KMSfirstwe picktwo determinate attributesforperceptual
mappingthan pickmajor competitors of KMSCorporation& the last stepof perpetual mapping
isgrowingscores.
STEP NO 1
We select two main attributes are;
1. QUALITY OF PRODUCT
2. BRAND REPUTATION
STEP NO 2
In thisstepwe selectcompetitorsof KMSCOMPANY;
1. Allmedsolutions,
2. Imran scientificcompany
STEP NO 3
In closingstepof perceptual mappingis developingscores.Accordingtoperceptualmapping
ALLMED solution score ishighdue tothe fact of high-quality &brandreputation.KMS
have highproductfantasticbut low brandreputation &IMRAN SCIENTIFEChave
productquality & brandreputation eachare low..
18. April 26, 2020 18
QUALITY OF PRODUCT
HIGH
BRAND REPUTATION
HIGH L0W
LOW
19. April 26, 2020 19
COMPANY PROBLEMS DURING COVID19:
Due to the Pandemic situation of COVID-19. The Import of
the company stops OR PARTIALLY on because of global lockdown
company took some steps to contact local manufacturer and make
possible supply to healthcare institutes at high purchasing coast of the
product, so the March which decrease the income of that month….
The Reasons of below Forecast of April is that in this month the import
is partially open due to the fact of lock down. More over there will
be additionally an influence of Ramadan due to which sales decreases.
20. April 26, 2020 20
3rd
and 4th
Quarter and the Years 2021
Moreover Company promiseto supply the Full income barring any
deductions.
There is no extra have an effect on of COVID-19 in 3rd or 4th quarter of
2020 and so on due to the
fact organization deals in neighborhood producer products which is
the need of healthcare institutes as the core patron have
no trouble of cash so they
will always purchasethese products as advocated via healthcare
professionals.
21. April 26, 2020 21
PROBLEM FACED BY COMPANY:
The important problem organization faces in quarter 1 Due to the Pandemic situation of COVID-
19. The Import of the organization stops due to the fact of lockdown. KMS l& China is
a important producer of low-coast diagnostics.
STRATEGY OF KMS IN FUTURE:
Now;organization implementsthe unique techniques toclearupout the issues happen due tothe
corona virus& company alsosolvesthe salesissues.
Companyhave nownot closeddown yetregardlessof goingthrough scarcityof imported
DIAGNOSTICS substances fromChinaandare as an alternative attemptingtosource them
fromdifferentsources.Now inthis state of affairsCompany
use those merchandise storage, whosave forextravolumeoneachand every monthin increase incase
for goingthrough any critical scenarioso employermakesuse of thisstorage material.
Now company use this STRATEGY dealingwithpandemicscenariodue toCOVID19.